Ruth McKernan, AstronauTx co-founder (SV Health Investors)
Novartis, Bristol Myers back $61M Series A raise for dementia biotech AstronauTx
Big Pharma-supported biotech AstronauTx has bagged £48 million ($61 million) in a Series A raise to advance its preclinical pipeline of small-molecule drugs for neurodegenerative …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.